Skip to content
Is Pfizer Recommending a Switch to a Single-Dose Policy?
Khaya Himmelman /

Is Pfizer Recommending a Switch to a Single-Dose Policy?

The vaccine has demonstrated a high efficacy rate after one dose, but the company itself has not suggested any policy changes.
Is Pfizer Recommending a Switch to a Single-Dose Policy?

In a letter to the New England Journal of Medicine on February 17, two Canadian researchers, Danuta Skowronski and Gaston De Serres, suggested “deferring second doses” of the COVID-19 vaccine “until all priority group members are offered at least one dose.” The suggestion is based on an analysis of documents from Pfizer that were submitted to the FDA, which found, among other things, that one single dose of the Pfizer vaccine is 92.6 percent effective against COVID-19.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Khaya Himmelman is a fact checker for The Dispatch. She is a graduate of Columbia Journalism School and Barnard College.

More We Think You’d Like

Loading